These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23074987)

  • 1. Using a build-and-click approach for producing structural and functional diversity in DNA-targeted hybrid anticancer agents.
    Ding S; Qiao X; Kucera GL; Bierbach U
    J Med Chem; 2012 Nov; 55(22):10198-203. PubMed ID: 23074987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redesigning the DNA-targeted chromophore in platinum-acridine anticancer agents: a structure-activity relationship study.
    Pickard AJ; Liu F; Bartenstein TF; Haines LG; Levine KE; Kucera GL; Bierbach U
    Chemistry; 2014 Dec; 20(49):16174-87. PubMed ID: 25302716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the DNA damage produced by a platinum-acridine antitumor agent and its effects in NCI-H460 lung cancer cells.
    Qiao X; Zeitany AE; Wright MW; Essader AS; Levine KE; Kucera GL; Bierbach U
    Metallomics; 2012 Jul; 4(7):645-52. PubMed ID: 22456976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, cytotoxicity and structure-activity relationships between ester and amide functionalities in novel acridine-based platinum(II) complexes.
    Bouyer F; Moretto J; Pertuit D; Szollosi A; Lacaille-Dubois MA; Blache Y; Chauffert B; Desbois N
    J Inorg Biochem; 2012 May; 110():51-7. PubMed ID: 22459174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a Chiral DNA-Targeted Platinum-Acridine Agent with Potent Enantioselective Anticancer Activity.
    Zhang S; Yao X; Watkins NH; Rose PK; Caruso SR; Day CS; Bierbach U
    Angew Chem Int Ed Engl; 2020 Dec; 59(49):21965-21970. PubMed ID: 32835419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, aqueous reactivity, and biological evaluation of carboxylic acid ester-functionalized platinum-acridine hybrid anticancer agents.
    Graham LA; Suryadi J; West TK; Kucera GL; Bierbach U
    J Med Chem; 2012 Sep; 55(17):7817-27. PubMed ID: 22871158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of linkage geometry on biological activity in thiourea- and guanidine-substituted acridines and platinum-acridines.
    Ma Z; Saluta G; Kucera GL; Bierbach U
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3799-801. PubMed ID: 18515101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Platinum-Acridine Anticancer Agent and Its Liposomal Formulation in an in vivo Model of Lung Adenocarcinoma.
    Ding S; Hackett CL; Liu F; Hackett RG; Bierbach U
    ChemMedChem; 2021 Jan; 16(2):412-419. PubMed ID: 32975041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteine-Directed Bioconjugation of a Platinum(II)-Acridine Anticancer Agent.
    Yao X; Tracy CM; Bierbach U
    Inorg Chem; 2019 Jan; 58(1):43-46. PubMed ID: 30543413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological activity, and DNA-damage profile of platinum-threading intercalator conjugates designed to target adenine.
    Guddneppanavar R; Saluta G; Kucera GL; Bierbach U
    J Med Chem; 2006 Jun; 49(11):3204-14. PubMed ID: 16722638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A non-cross-linking platinum-acridine agent with potent activity in non-small-cell lung cancer.
    Ma Z; Choudhury JR; Wright MW; Day CS; Saluta G; Kucera GL; Bierbach U
    J Med Chem; 2008 Dec; 51(23):7574-80. PubMed ID: 19012390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-binding antitumor agents: from pyrimido[5,6,1-de]acridines to other intriguing classes of acridine derivatives.
    Antonini I
    Curr Med Chem; 2002 Sep; 9(18):1701-16. PubMed ID: 12171552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
    Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
    J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermally inert metal ammines as light-inducible DNA-targeted agents. Synthesis, photochemistry, and photobiology of a prototypical rhodium(III)-intercalator conjugate.
    Barry CG; Turney EC; Day CS; Saluta G; Kucera GL; Bierbach U
    Inorg Chem; 2002 Dec; 41(26):7159-69. PubMed ID: 12495358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unprecedented monofunctional metalation of adenine nucleobase in guanine- and thymine-containing dinucleotide sequences by a cytotoxic platinum-acridine hybrid agent.
    Barry CG; Baruah H; Bierbach U
    J Am Chem Soc; 2003 Aug; 125(32):9629-37. PubMed ID: 12904029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-Pore Functionalized Mesoporous Silica Nanoparticles as Drug Delivery Vector for a Highly Cytotoxic Hybrid Platinum-Acridine Anticancer Agent.
    Zheng Y; Fahrenholtz CD; Hackett CL; Ding S; Day CS; Dhall R; Marrs GS; Gross MD; Singh R; Bierbach U
    Chemistry; 2017 Mar; 23(14):3386-3397. PubMed ID: 28122141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A non-crosslinking platinum-acridine hybrid agent shows enhanced cytotoxicity compared to clinical BCNU and cisplatin in glioblastoma cells.
    Hess SM; Anderson JG; Bierbach U
    Bioorg Med Chem Lett; 2005 Jan; 15(2):443-6. PubMed ID: 15603970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linker design for the modular assembly of multifunctional and targeted platinum(ii)-containing anticancer agents.
    Ding S; Bierbach U
    Dalton Trans; 2016 Aug; 45(33):13104-13. PubMed ID: 27251881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Prodrug-Payloads for Targeted Therapeutic Applications of Platinum-Acridine Anticancer Agents.
    Mancera-Ortiz IY; Chen J; Slade TA; Yao X; Zhang S; Day CS; Bierbach U
    Bioconjug Chem; 2023 Oct; 34(10):1873-1881. PubMed ID: 37813818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative chemogenomics to examine the mechanism of action of dna-targeted platinum-acridine anticancer agents.
    Cheung-Ong K; Song KT; Ma Z; Shabtai D; Lee AY; Gallo D; Heisler LE; Brown GW; Bierbach U; Giaever G; Nislow C
    ACS Chem Biol; 2012 Nov; 7(11):1892-901. PubMed ID: 22928710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.